BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29928370)

  • 1. Retinoic acid-metabolizing enzyme cytochrome P450 26A1 promotes skin carcinogenesis induced by 7,12-dimethylbenz[a]anthracene.
    Osanai M; Takasawa A; Takasawa K; Murata M; Sawada N
    Oncol Lett; 2018 Jun; 15(6):9987-9993. PubMed ID: 29928370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoic acid-metabolizing enzyme cytochrome P450 26a1 (cyp26a1) is essential for implantation: functional study of its role in early pregnancy.
    Han BC; Xia HF; Sun J; Yang Y; Peng JP
    J Cell Physiol; 2010 May; 223(2):471-9. PubMed ID: 20112286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NTP Toxicology and Carcinogenesis Studies of o-Phenylphenol (CAS No. 90-43-7) Alone and with 7,12-Dimethylbenz(a)anthracene (CAS No. 57-97-6) in Swiss CD-1 Mice (Dermal Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1986 Mar; 301():1-141. PubMed ID: 12748705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NTP Initiation/Promotion Study of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in Swiss (CD-1(R)) Mice (Mouse Skin Study).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1995 May; 444():1-136. PubMed ID: 12595919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone.
    Verma AK; Garcia CT; Ashendel CL; Boutwell RK
    Cancer Res; 1983 Jul; 43(7):3045-9. PubMed ID: 6406052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dietary retinoic acid prevents malignant conversion of skin papillomas induced by a two-stage carcinogenesis protocol in female SENCAR mice.
    Chen LC; Sly L; De Luca LM
    Carcinogenesis; 1994 Oct; 15(10):2383-6. PubMed ID: 7955082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of c-Ha-ras gene mutations in skin tumors induced in carcinogenesis-susceptible and carcinogenesis-resistant mice by different two-stage protocols or tumor promoter alone.
    Pazzaglia S; Mancuso M; Primerano B; Rebessi S; Biozzi G; Covelli V; Saran A
    Mol Carcinog; 2001 Feb; 30(2):111-8. PubMed ID: 11241758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of excess dietary retinoic acid on skin papilloma and carcinoma formation induced by a complete carcinogenesis protocol in female Sencar mice.
    Chen LC; Kirchhoff S; De Luca LM
    Cancer Lett; 1994 Apr; 78(1-3):63-7. PubMed ID: 8180970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-stage carcinogenesis in NMRI mice: intravaginal application of 7,12-dimethylbenz[a]anthracene as initiator followed by the phorbol ester 12-O-tetradecanoylphorbol-13-acetate as promoter.
    Goerttler K; Löhrke H; Hesse B
    Carcinogenesis; 1980 Aug; 1(8):707-13. PubMed ID: 11272124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced expression of retinoic acid-metabolizing enzyme CYP26A1 in sunlight-damaged human skin.
    Osanai M; Lee GH
    Med Mol Morphol; 2011 Dec; 44(4):200-6. PubMed ID: 22179182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homology Models and Molecular Modeling of Human Retinoic Acid Metabolizing Enzymes Cytochrome P450 26A1 (CYP26A1) and P450 26B1 (CYP26B1).
    Karlsson M; Strid Å; Sirsjö A; Eriksson LA
    J Chem Theory Comput; 2008 Jun; 4(6):1021-7. PubMed ID: 26621242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of NADPH-cytochrome P450 reductase on all-trans-retinoic acid efficacy and cytochrome P450 26A1 expression in human myeloid leukaemia HL-60 cells.
    Hu L; Lv JF; Zhuo W; Zhang CM; Zhou HH; Fan L
    J Pharm Pharmacol; 2016 Sep; 68(9):1193-202. PubMed ID: 27366899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abrogation of protein phosphatase 6 promotes skin carcinogenesis induced by DMBA.
    Hayashi K; Momoi Y; Tanuma N; Kishimoto A; Ogoh H; Kato H; Suzuki M; Sakamoto Y; Inoue Y; Nomura M; Kiyonari H; Sakayori M; Fukamachi K; Kakugawa Y; Yamashita Y; Ito S; Sato I; Suzuki A; Nishio M; Suganuma M; Watanabe T; Shima H
    Oncogene; 2015 Aug; 34(35):4647-55. PubMed ID: 25486434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a new model of tumor progression from carcinogenesis and tumor promotion studies with 7-bromomethylbenz[a]anthracene.
    Scribner JD; Scribner NK; McKnight B; Mottet NK
    Cancer Res; 1983 May; 43(5):2034-41. PubMed ID: 6403231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced sensitivity to tumor growth and development in multistage skin carcinogenesis by transforming growth factor-alpha-induced epidermal growth factor receptor activation but not p53 inactivation.
    Shibata MA; Ward JM; Green JE; Merlino G
    Mol Carcinog; 1997 Mar; 18(3):160-70. PubMed ID: 9115586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of promotion of 7,12-dimethylbenz[a]anthracene-initiated mouse skin carcinogenesis by 1.5 GHz electromagnetic near fields.
    Imaida K; Kuzutani K; Wang J; Fujiwara O; Ogiso T; Kato K; Shirai T
    Carcinogenesis; 2001 Nov; 22(11):1837-41. PubMed ID: 11698347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of the retinoic acid-metabolizing enzyme CYP26A1 during the progression of cervical squamous neoplasia and head and neck cancer.
    Osanai M; Lee GH
    BMC Res Notes; 2014 Oct; 7():697. PubMed ID: 25294402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium o-phenylphenate (OPP-Na) promotes skin carcinogenesis in CD-1 female mice initiated with 7,12-dimethylbenz[a]anthracene.
    Takahashi M; Sato H; Toyoda K; Furukawa F; Imaida K; Hasegawa R; Hayashi Y
    Carcinogenesis; 1989 Jul; 10(7):1163-7. PubMed ID: 2500267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols.
    Iversen OH
    APMIS Suppl; 1994; 41():1-38. PubMed ID: 7946481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
    Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
    Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.